Skip to content
Screener

Fortress Biotech FBIO Q1 2026 Annual earnings

Reported May 14, 2026 · After market close

Revenue$16.0MMiss by $300.0K
EPS$2.82Beat by $3.04
Revenue estimate$16.3M
EPS estimate-$0.22

Next report

Nov 16, 2026 (in 3 months)
Revenue estimate$21.6M
EPS estimate-$0.27

FAQ

When did Fortress Biotech report Q1 2026 earnings?
Fortress Biotech (FBIO) reported Q1 2026 earnings on May 14, 2026 after market close.
What were Fortress Biotech's Q1 2026 revenue and EPS?
Fortress Biotech reported revenue of $16.0M and eps of $2.82 for Q1 2026.
Did Fortress Biotech beat estimates in Q1 2026?
Revenue missed the consensus estimate of $16.3M by $300.0K. EPS beat the consensus estimate of $-0.22 by $3.04.
How did Fortress Biotech's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.1% from $13.1M a year earlier.
Where can I find Fortress Biotech's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-061208) and the 10-K periodic report (0001104659-26-037874) directly on SEC EDGAR. The filing index links above go to sec.gov.